UCB/€UCB
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About UCB
UCB SA, founded in 1928, is a global biopharmaceutical company headquartered in Brussels, Belgium. The company specializes in the research, development, and commercialization of innovative therapies primarily for the treatment of neurological and immunological disorders. Operating in the healthcare sector, UCB is dedicated to advancing science and addressing unmet medical needs for patients worldwide.
Ticker
€UCB
Sector
Trading on
BSE
Industry
Pharmaceuticals
Headquarters
Employees
9,215
ISIN
BE0003739530
Website
UCB Metrics
BasicAdvanced
€30B
27.76
€5.61
0.34
€0.97
0.63%
Price and volume
Market cap
€30B
Beta
0.34
52-week high
€198.95
52-week low
€125.50
Average daily volume
271K
Dividend rate
€0.97
Financial strength
Current ratio
1.357
Quick ratio
0.871
Long term debt to equity
29.544
Total debt to equity
30.172
Dividend payout ratio (TTM)
24.32%
Interest coverage (TTM)
5.19%
Management effectiveness
Return on assets (TTM)
3.22%
Return on equity (TTM)
11.21%
Valuation
Price to earnings (TTM)
27.76
Price to revenue (TTM)
4.806
Price to book
2.94
Price to tangible book (TTM)
60.83
Price to free cash flow (TTM)
32.132
Dividend yield (TTM)
0.63%
Forward dividend yield
0.63%
Growth
Revenue change (TTM)
18.72%
Earnings per share change (TTM)
218.48%
3-year revenue growth (CAGR)
2.12%
3-year earnings per share growth (CAGR)
0.91%
3-year dividend per share growth (CAGR)
2.26%
What the Analysts think about UCB
Analyst ratings (Buy, Hold, Sell) for UCB stock.
UCB Financial Performance
Revenues and expenses
UCB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for UCB stock?
UCB (UCB) has a market cap of €30B as of May 30, 2025.
What is the P/E ratio for UCB stock?
The price to earnings (P/E) ratio for UCB (UCB) stock is 27.76 as of May 30, 2025.
Does UCB stock pay dividends?
Yes, the UCB (UCB) stock pays dividends to shareholders. As of May 30, 2025, the dividend rate is €0.973 and the yield is 0.63%. UCB has a payout ratio of 24.32% on a trailing twelve-month basis.
When is the next UCB dividend payment date?
The next UCB (UCB) dividend payment date is unconfirmed.
What is the beta indicator for UCB?
UCB (UCB) has a beta rating of 0.34. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.